Replies to post #760 on Galectin Therapeutics Inc. (GALT)

[biotech2010]

While I'm a little disappointed that there was no spike after hours there is still lots of opportunity for a share price increase in the next few days, all it really takes is one of the analysts raising their price target or an additional analyst initiating coverage with a Buy rating, both of which could clearly happen.